☆ 4.7 Article

Imaging-Based Prevalence of Oligometastatic Disease: A Single-Center Cross-Sectional Study

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Related references

Note: Only part of the references are listed.

Article Oncology

Pan-cancer analysis of prognostic metastatic phenotypes

Nicholas G. Zaorsky et al.

Summary: This project aimed to redefine staging of metastatic cancer, identified five metastatic phenotypes through latent class analysis, and found long-term survivors. All metastatic cancer is considered as Stage IV disease.

INTERNATIONAL JOURNAL OF CANCER (2022)

Add to Collection

Article Oncology

Evaluation of the prognostic value of the ESTRO EORTC classification of oligometastatic disease in patients treated with stereotactic body radiotherapy: A retrospective single center study

Jonas Willmann et al.

Summary: The study aimed to investigate the prognostic value of the oligometastatic disease (OMD) states according to the European Society for Radiotherapy and Oncology (ESTRO) classification system. The results showed significant differences in survival outcomes for different types of OMD patients, and the classification system had moderate discriminatory strength. Further large multicenter trials are needed to validate the prognostic power of the classification system in different types of OMD patients.

RADIOTHERAPY AND ONCOLOGY (2022)

Add to Collection

Article Oncology

Imaging and its Impact on Defining the Oligometastatic State

Ali Pirasteh et al.

Summary: Successful treatment of oligometastatic disease relies on timely detection and localization, with imaging playing a crucial role. Challenges in managing OMD are reflected in imaging, despite technological advances. This review highlights the role of imaging in detecting and evaluating OMD in various organ systems, aiming to provide practical guidance for clinicians.

SEMINARS IN RADIATION ONCOLOGY (2021)

Add to Collection

Review Oncology

Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis

Elisa Gobbini et al.

Summary: This study aimed to describe the incidence and clinical characteristics of oligometastatic non-small cell lung cancer patients, finding that oligometastatic status is recognized as a distinct clinical condition from multi metastatic NSCLC with different prognosis. Consistent clinical features were observed in the general metastatic population, with brain and bones being the most frequent organs involved.

TRANSLATIONAL LUNG CANCER RESEARCH (2021)

Add to Collection

Article Oncology

Current usage of stereotactic body radiotherapy for oligometastatic prostate cancer in Korea: patterns of care survey (KROG 19-08)

Sun Hyun Bae et al.

Summary: There is diversity in the patterns of curative-intent SBRT for OMPC in Korea, with a certain proportion of radiation oncologists in the past year using SBRT to treat OMPC patients. There are differences in defining SBRT in terms of dose and fraction number among physicians.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Add to Collection

Review Oncology

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

Matthias Guckenberger et al.

LANCET ONCOLOGY (2020)

Add to Collection

Article Oncology

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer The ORIOLE Phase 2 Randomized Clinical Trial

Ryan Phillips et al.

JAMA ONCOLOGY (2020)

Add to Collection

Article Oncology

Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document

Yolande Lievens et al.

RADIOTHERAPY AND ONCOLOGY (2020)

Add to Collection

Article Oncology

Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study

Anastasia Chalkidou et al.

LANCET ONCOLOGY (2020)

Add to Collection

Review Oncology

Circulating Tumor DNA Biomarkers for Early Detection of Oligometastasis

David M. Routman et al.

CANCER JOURNAL (2020)

Add to Collection

Article Oncology

A Multicenter Prospective Clinical Trial of 68Gallium PSMA HBED-CC PET-CT Restaging in Biochemically Relapsed Prostate Carcinoma: Oligometastatic Rate and Distribution Compared With Standard Imaging

Michael McCarthy et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Add to Collection

Article Oncology

Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study

Daniel R. Gomez et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

David A. Palma et al.

LANCET (2019)

Add to Collection

Article Oncology

Multidisciplinary Tumor Board Recommendations for Oligometastatic Malignancies: A Prospective Single-Center Analysis

Christian Galata et al.

ONCOLOGY RESEARCH AND TREATMENT (2019)

Add to Collection

Review Oncology

Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group

Nandita M. deSouza et al.

EUROPEAN JOURNAL OF CANCER (2018)

Add to Collection

Article Oncology

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

Piet Ost et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Add to Collection

Article Oncology

Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer A Phase 2 Randomized Clinical Trial

Puneeth Iyengar et al.

JAMA ONCOLOGY (2018)

Add to Collection

Review Oncology

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group

Frederic E. Lecouvet et al.

LANCET ONCOLOGY (2018)

Add to Collection

Article Oncology

Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients

C. Collen et al.

ANNALS OF ONCOLOGY (2014)

Add to Collection

Article Oncology

The oligometastatic state-separating truth from wishful thinking

David A. Palma et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2014)

Add to Collection

Article Oncology

Radical Treatment of Non-Small-Cell Lung Cancer Patients with Synchronous Oligometastases Long-Term Results of a Prospective Phase II Trial (Nct01282450)

Dirk De Ruysscher et al.

JOURNAL OF THORACIC ONCOLOGY (2012)

Add to Collection

Article Oncology

Oligometastases revisited

Ralph R. Weichselbaum et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.